comparemela.com
Home
Live Updates
Trevena (NASDAQ: TRVN): A Biotech Low Float Runner : comparemela.com
Trevena (NASDAQ: TRVN): A Biotech Low Float Runner
Trevena (NASDAQ: TRVN) announced that its partner, Jiangsu Nhwa, has received approval from China's National Medical Products Administration (NMPA) for its opioid pain medication, Olinvyk.
Related Keywords
China
,
Jiangsu Nhwa
,
Carrie Bourdow
,
Healthcare Fund
,
Exchange Commission
,
China National Medical Products Administration
,
National Medical Products Administration
,
R Bridge Healthcare Fund
,
R Bridge Financing
,
Inside Scoop
,
Right Now
,
Stock Halt Alerts
,
Dell Thomas Investing
,
Featured
,
Trvn
,
comparemela.com © 2020. All Rights Reserved.